Numerous preclinical and animal studies have previously demonstrated that FAP-expressing stroma is a critical component of the TME that inhibit antitumor immunity (11, 13, 17–19) and depleting FAP+ stroma suppresses tumor growth and restores antitumor immunity (20–25). The gene discussed is FAP; the disease is neoplasm.